IBDEI1XR ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30918,1,4,0)
 ;;=4^N05.3
 ;;^UTILITY(U,$J,358.3,30918,2)
 ;;=^5015544
 ;;^UTILITY(U,$J,358.3,30919,0)
 ;;=N05.4^^123^1597^44
 ;;^UTILITY(U,$J,358.3,30919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30919,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,30919,1,4,0)
 ;;=4^N05.4
 ;;^UTILITY(U,$J,358.3,30919,2)
 ;;=^5015545
 ;;^UTILITY(U,$J,358.3,30920,0)
 ;;=N05.5^^123^1597^47
 ;;^UTILITY(U,$J,358.3,30920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30920,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,30920,1,4,0)
 ;;=4^N05.5
 ;;^UTILITY(U,$J,358.3,30920,2)
 ;;=^5015546
 ;;^UTILITY(U,$J,358.3,30921,0)
 ;;=N05.6^^123^1597^42
 ;;^UTILITY(U,$J,358.3,30921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30921,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,30921,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,30921,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,30922,0)
 ;;=N05.7^^123^1597^43
 ;;^UTILITY(U,$J,358.3,30922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30922,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,30922,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,30922,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,30923,0)
 ;;=N05.8^^123^1597^50
 ;;^UTILITY(U,$J,358.3,30923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30923,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ oth morphologic changes
 ;;^UTILITY(U,$J,358.3,30923,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,30923,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,30924,0)
 ;;=N05.9^^123^1597^51
 ;;^UTILITY(U,$J,358.3,30924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30924,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
 ;;^UTILITY(U,$J,358.3,30924,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,30924,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,30925,0)
 ;;=N06.0^^123^1597^39
 ;;^UTILITY(U,$J,358.3,30925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30925,1,3,0)
 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,30925,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,30925,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,30926,0)
 ;;=N06.1^^123^1597^38
 ;;^UTILITY(U,$J,358.3,30926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30926,1,3,0)
 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,30926,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,30926,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,30927,0)
 ;;=N06.2^^123^1597^35
 ;;^UTILITY(U,$J,358.3,30927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30927,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,30927,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,30927,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,30928,0)
 ;;=N06.3^^123^1597^36
 ;;^UTILITY(U,$J,358.3,30928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30928,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,30928,1,4,0)
 ;;=4^N06.3
 ;;^UTILITY(U,$J,358.3,30928,2)
 ;;=^5015552
 ;;^UTILITY(U,$J,358.3,30929,0)
 ;;=N06.4^^123^1597^34
 ;;^UTILITY(U,$J,358.3,30929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30929,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,30929,1,4,0)
 ;;=4^N06.4
 ;;^UTILITY(U,$J,358.3,30929,2)
 ;;=^5015553
